Lincoln Pharmaceuticals Limited has submitted the Exchange a copy of Voting Results of Annual General Meeting held on September 30, 2025
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has filed with the stock exchanges the official voting results from its Annual General Meeting (AGM) held on September 30, 2025. This is a routine regulatory disclosure required under SEBI listing rules, showing how shareholders voted on key resolutions such as adoption of financial statements, director appointments, auditor re-appointment, and any special business items. The filing allows investors and the public to review whether resolutions were passed by requisite majority. Specific vote tallies and resolution-wise outcomes would be detailed in the attached PDF.
This is a procedural compliance filing with no direct impact on stock price. Investors should review the detailed voting results to check approval percentages and any contested resolutions, which could signal shareholder dissent on management proposals.